Close

Analyst Ratings for First Wave BioPharma, Inc. (FWBI)

FWBI Rating Summary

FWBI Price Target Summary

* Over Last 12-Mos
  |   Expand Research on FWBI
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $25.00 (+1523.4%) * Over Last 12-Mos
Rating Score: 0 / 10   Percentile Rank: 0%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/7/2021 Maxim Group Naz Rahman Downgrade Hold
(Buy)
N/A
(N/A)
1.40
(1.54)
10% Details
Like FWBI Ratings? Also take a look at PETV

FWBI Ratings News